INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 204 filers reported holding INSMED INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,872,669 | +20.7% | 192,977 | +0.9% | 0.00% | +33.3% |
| Q2 2023 | $4,035,459 | +3.1% | 191,254 | -16.7% | 0.00% | 0.0% |
| Q1 2023 | $3,914,646 | -17.1% | 229,598 | -2.9% | 0.00% | -25.0% |
| Q4 2022 | $4,723,332 | -12.1% | 236,403 | -5.2% | 0.00% | -20.0% |
| Q3 2022 | $5,374,000 | +26.2% | 249,498 | +15.6% | 0.01% | +25.0% |
| Q2 2022 | $4,258,000 | -16.1% | 215,907 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,074,000 | -22.7% | 215,907 | -10.4% | 0.00% | 0.0% |
| Q4 2021 | $6,567,000 | -0.2% | 241,081 | +0.9% | 0.00% | -20.0% |
| Q3 2021 | $6,580,000 | +2.0% | 238,939 | +5.4% | 0.01% | 0.0% |
| Q2 2021 | $6,453,000 | -21.6% | 226,747 | -6.2% | 0.01% | -16.7% |
| Q1 2021 | $8,230,000 | -2.1% | 241,647 | -4.3% | 0.01% | 0.0% |
| Q4 2020 | $8,403,000 | +14.0% | 252,406 | +10.1% | 0.01% | -14.3% |
| Q3 2020 | $7,370,000 | +30.6% | 229,321 | +11.9% | 0.01% | +16.7% |
| Q2 2020 | $5,643,000 | +94.0% | 204,900 | +12.9% | 0.01% | +50.0% |
| Q1 2020 | $2,909,000 | -55.2% | 181,500 | -33.3% | 0.00% | -33.3% |
| Q4 2019 | $6,498,000 | +149.1% | 272,103 | +84.0% | 0.01% | +100.0% |
| Q3 2019 | $2,609,000 | -10.0% | 147,903 | +30.6% | 0.00% | 0.0% |
| Q2 2019 | $2,900,000 | -13.8% | 113,282 | -2.2% | 0.00% | -25.0% |
| Q1 2019 | $3,366,000 | +148.0% | 115,782 | +12.0% | 0.00% | +100.0% |
| Q4 2018 | $1,357,000 | -47.0% | 103,400 | -18.4% | 0.00% | -33.3% |
| Q3 2018 | $2,562,000 | -20.4% | 126,700 | -6.9% | 0.00% | -25.0% |
| Q2 2018 | $3,219,000 | -3.2% | 136,100 | -7.8% | 0.00% | -20.0% |
| Q1 2018 | $3,324,000 | +23.1% | 147,600 | +70.4% | 0.01% | +25.0% |
| Q4 2017 | $2,700,000 | +4.7% | 86,600 | +4.8% | 0.00% | 0.0% |
| Q3 2017 | $2,578,000 | +81.9% | 82,600 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $1,417,000 | -2.0% | 82,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,446,000 | +26.8% | 82,600 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $1,140,000 | -8.9% | 86,200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,252,000 | +37.9% | 86,200 | -6.4% | 0.00% | +100.0% |
| Q2 2016 | $908,000 | -24.6% | 92,100 | -3.1% | 0.00% | -50.0% |
| Q1 2016 | $1,204,000 | -34.2% | 95,000 | -5.8% | 0.00% | -33.3% |
| Q4 2015 | $1,830,000 | -20.5% | 100,800 | -18.7% | 0.00% | -25.0% |
| Q3 2015 | $2,303,000 | -6.5% | 124,000 | +23.0% | 0.00% | 0.0% |
| Q2 2015 | $2,462,000 | +53.5% | 100,800 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $1,604,000 | 0.0% | 100,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,604,000 | -6.8% | 100,800 | -23.5% | 0.00% | 0.0% |
| Q3 2014 | $1,721,000 | -29.9% | 131,848 | +7.3% | 0.00% | -33.3% |
| Q2 2014 | $2,455,000 | +21.8% | 122,857 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $2,016,000 | +17.7% | 122,857 | +21.9% | 0.00% | +50.0% |
| Q4 2013 | $1,713,000 | +7.6% | 100,800 | -1.2% | 0.00% | -33.3% |
| Q3 2013 | $1,592,000 | +50.9% | 102,000 | +15.6% | 0.00% | +50.0% |
| Q2 2013 | $1,055,000 | – | 88,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |